Search

everythinglearnresearchcommunity

for

Search:↓

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

CD73 may regulate hair growth and could be targeted for hair growth treatments.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

RTA 408 cream protects mice from radiation skin damage.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Dendrobium candidum polysaccharides promote hair growth.

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.